This webinar, presented by Laura Ceriotti (Regulatory Specialist) and Paolo Buratti (GLP Study Director), showcased the opportunities offered by 3D reconstructed human tissues to demonstrate the physical mode of action of substance-based medical devices in line with the requirements of the EU Medical Device Regulation 2017/745 (MDR).